Please login to the form below

Not currently logged in
Email:
Password:

ADA meeting

This page shows the latest ADA meeting news and features for those working in and with pharma, biotech and healthcare.

J&J says real-world data finds no amputation risk for Invokana

J&J says real-world data finds no amputation risk for Invokana

Now, J&J has data from a patient registry involving more than 140, 000 type 2 diabetics treated with Invokana (canagliflozin) – reported at the American Diabetes Association (ADA) meeting in Orlando,

Latest news

  • Novo says real-world data backs its insulin switching Novo says real-world data backs its insulin switching

    The Danish drugmaker reported findings from its EU-TREAT patient registry study at the American Diabetes Association (ADA) meeting in San Diego on Saturday. ... Top-line data from that trial was reported late last month and will be presented as a keynote

  • IBM plans Watson-powered 'diabetes advisor' IBM plans Watson-powered 'diabetes advisor'

    The collaboration will marry IBM's Watson supercomputer with the vast repository of clinical and research data held by the ADA. ... Announcing the tie-up at the ADA's annual scientific meeting earlier this month, IBM and the ADA also outlined their plans

  • Rivals look to put pressure on Sanofi's Lantus Rivals look to put pressure on Sanofi's Lantus

    Novo Nordisk and Lilly claim clinical benefitsover top-selling diabetes drug.  . The American Diabetes Association's (ADA) Scientific Sessions meeting in Boston this weekend saw several of Sanofi's rivals claim ... of patients reaching the ADA's target

  • Relief as study finds no cardiovascular risk with Januvia Relief as study finds no cardiovascular risk with Januvia

    The data will be scrutinised further when presented at the American Diabetes Association (ADA) meeting in Boston in June, but analysts suggested the results could help Januvia consolidate its position as

  • AZ and Takeda drugs should carry heart failure warning AZ and Takeda drugs should carry heart failure warning

    With that in mind, attention is fixed on the forthcoming results from the TECOS trial of Januvia, which are due to be presented at the American Diabetes Association (ADA) meeting in

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics